Patients report improvement in haemorrhoid treatment trial
Drug Discovery World
JUNE 21, 2023
Citius Pharmaceuticals has revealed positive results from its Phase IIb Study of Halo-Lido (CITI-002) for the treatment of haemorrhoids. Moreover, there were no reported significant adverse events and CITI-002 was well tolerated by patients in the study.
Let's personalize your content